UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16
OF THE SECURITIES EXCHANGE ACT OF 1934
June 21, 2019
(Commission File No. 001-38475)
ASLAN PHARMACEUTICALS LIMITED
(REG. NO. 289175)
(Translation of registrant’s name into English)
CAYMAN ISLANDS
(Jurisdiction of incorporation or organisation)
83 CLEMENCEAU AVENUE
#12-03 UE SQUARE
SINGAPORE 239920
(Address of registrant’s principal executive office)
Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.
Form 20-F ☒ Form 40-F ☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101 (b) (1):
Yes ☐ No ☒
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101 (b) (7):
Yes ☐ No ☒
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereto duly authorized.
|
|
|
|
ASLAN PHARMACEUTICALS LIMITED |
|
|
(Registrant) |
|
|
|
|
|
By: |
/s/ Kiran Kumar Asarpota
|
|
Name: |
Kiran Kumar Asarpota |
|
Title: |
VP Finance |
Date: June 21, 2019
Announcement of the re-election results of Board of Directors (including independent directors)
|
|
1. |
Date of occurrence of the change: 2019/06/21 |
|
|
2. |
Appointment of or changed personnel: Directors and Independent directors |
|
|
3. |
Title, name and resume of the replaced person – before: |
|
Title: |
Name: |
Resume: |
|
Chairman |
Carl Firth |
Ex-Chairman of the company |
|
Director |
Alnair Investment |
Representative of director: Jun Wu |
|
Director |
BV Healthcare II Pte. Ltd. |
Representative of director：Lim Chin Hwee Damien |
|
INED |
Andrew James Howden |
INED of the company |
|
INED |
Chin-Feng Sun |
INED of the company |
|
INED |
Robert E. Hoffman |
INED of the company |
|
|
4. |
Title, name and resume of the replacement – after: |
|
Title: |
Name: |
Resume: |
|
Director |
Carl Firth |
new-elected director of the company |
|
Director |
Alnair Investment |
new-elected director of the company; representative of director – Jun Wu |
|
Director |
BV Healthcare II Pte. Ltd. |
new-elected director of the company; representative of director – Lim Chin Hwee Damien |
|
INED |
Andrew James Howden |
new-elected INED of the company |
|
INED |
Chin-Feng Sun |
new-elected INED of the company |
|
INED |
Robert E. Hoffman |
new-elected INED of the company |
|
|
5. |
Type of change: expiry of term of office |
|
|
6. |
Reason for the change: Re-election |
|
|
7. |
Number of shares held by the new personnel at the time of appointment: |
|
Title: |
Name: |
Number of shares |
|
Director |
Carl Firth |
0 shares * |
|
Director |
Alnair Investment |
8,823,528 shares ** |
|
Director |
BV Healthcare II Pte. Ltd. |
7,542,112 shares |
|
INED |
Andrew James Howden |
439,510 shares |
|
INED |
Chin-Feng Sun |
0 shares |
|
INED |
Robert E. Hoffman |
0 shares |
|
|
8. |
Original term: from 2016/04/15 to 2019/04/14 |
|
|
10. |
Rate of turnover of directors of the same term: NA |
|
|
11. |
Rate of turnover of supervisors of the same term: NA |
|
|
12. |
Rate of turnover of independent directors of the same term: NA |
|
|
13. |
Change in one-third or more of directors (“Yes” or “No”): Yes |
|
|
14. |
Any other matters that need to be specified: |
* Director Carl Firth holds his shares under a company Kimba Capital and the total number of shares are 3,344,340.
** Director Alnair Investment holds shares under a company Shanghai Cenova and the total number of shares are 1,063,830.